CNS Drugs

Amyotrophic Lateral Sclerosis: Pathophysiology, Diagnosis and Management
pp. 1-15(15)
Author: Gordon, Paul H.

Achieving Remission as a Routine Goal of Pharmacotherapy in Attention-Deficit Hyperactivity Disorder
pp. 17-36(20)
Authors: Ramos-Quiroga, J. Antoni; Casas, Miguel

Oral Therapies for Multiple Sclerosis: A Review of Agents in Phase III Development or Recently Approved
pp. 37-52(16)
Author: Gold, Ralf

The Association between Adherence to Levodopa/Carbidopa/Entacapone Therapy and Healthcare Utilization and Costs among Patients with Parkinson's Disease: A Retrospective Claims-Based Analysis
pp. 53-66(14)
Authors: Delea, Thomas E.; Thomas, Simu K.; Hagiwara, May

Interferon-β-1b: A Review of its Use in Multiple Sclerosis
pp. 67-88(22)
Author: Plosker, Greg L.